Braude, PhilipCarter, BenShort, RoxannaVilches-Moraga, ArturoVerduri, AlessiaLyndsay Pearce, MissAngeline Price, MissQuinn, Terence JStechman, MichaelCollins, JemimaBruce, EilidhEinarsson, AliceRickard, FrancesMitchell, EmmaHolloway, MarkHesford, JamesBarlow-Pay, FenellaClini, EnricoKyaw Myint, PhyoMoug, SusanMcCarthy, KathrynHewitt, Jonathan2021-12-062021-12-062020-12-01Braude, P, Carter, B, Short, R, Vilches-Moraga, A, Verduri, A, Lyndsay Pearce, M, Angeline Price, M, Quinn, T J, Stechman, M, Collins, J, Bruce, E, Einarsson, A, Rickard, F, Mitchell, E, Holloway, M, Hesford, J, Barlow-Pay, F, Clini, E, Kyaw Myint, P, Moug, S, McCarthy, K & Hewitt, J 2020, 'The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19', IJC Heart & Vasculature, vol. 31, 100660. https://doi.org/10.1016/j.ijcha.2020.1006602352-9067PubMedCentral: PMC7561344ORCID: /0000-0003-3852-6158/work/163198801https://hdl.handle.net/2164/176227310902engCoronavirusAngiotensin receptor antagonistsangiotensin-converting enzyme inhibitorshospitalizationhospital mortalityAngiotensin-converting enzyme inhibitorsHospital mortalityHospitalizationR MedicineCardiology and Cardiovascular MedicineSupplementary Datahttps://doi.org/10.1016/j.ijcha.2020.100660RThe influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19Journal article10.1016/j.ijcha.2020.100660http://www.scopus.com/inward/record.url?scp=85094813576&partnerID=8YFLogxK31